The liver as a central "hub" of the immune system: pathophysiological implications.
vol.105 iss.2 (2025) Degenerate neuronal and circuit mechanisms important for generating rhythmic motor patterns.
vol.105 iss.1 (2025) Psycho-physiological foundations of human physical activity behavior and motivation: Theories, systems, mechanisms, evolution, and genetics.
(2025) The (dys)regulation of energy storage in obesity.
(2025) Kisspeptin and Neurokinin B: roles in reproductive health.
(2025) NADPH Oxidases: Redox Regulation of Cell Homeostasis & Disease.
(2025) The TRP Channels Serving as Chemical-to-Electrical Signal Converter.
(2025) Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans.
(2025) Molecular Dissection of the Role of ACE2 in Glucose Homeostasis.
(2025) Physiologic mechanisms underlying polycystic kidney disease.
(2025) The influence of extracellular vesicles on tumor evolution and resistance to therapy.
(2025) The flux of energy in critical illness and the obesity paradox.
(2025) The pathogenesis of cerebral small vessel diseases and vascular cognitive impairment.
(2025) Neuropathological links between T2DM and LOAD: systematic review and meta-analysis.
(2025) Biomarkers of aging: from molecules and surrogates to physiology and function.
(2025) Extracellular vesicles and lung disease: from pathogenesis to biomarkers and treatments.
(2025) Transforming the concept of connectivity: unveiling tunneling nanotube biology, and their roles in brain development and neurodegeneration.
(2025) TPCs: From plant to human.
(2025) Uterine Fibroids.
(2025) A Comprehensive View of Muscle Glucose Uptake: Regulation by Insulin, Contractile Activity and Exercise.
(2025) Central nervous system mechanisms of salt-sensitive hypertension.
(2025) Deconstructing the GWAS library - Next Generation GWAS.
(2025) Immunotherapy for atherosclerosis.
(2025) Cysteine-based redox sensors in the cardiovascular system - from identification to physiology and drug discovery.
(2025) The human placenta and its role in reproductive outcomes revisited.
(2025) The physiopathology of brain-derived neurotrophic factor.
(2025) Glycerolipid Cycling in Thermogenesis, Energy Homeostasis and Signaling.
(2025) Immunomodulatory properties of transmembrane mucins: from chronic diseases to cancer.
(2025) Programmed cell death and tissue regeneration: A link that should be resolved.
(2025) Diaphragm Muscle: A Pump That Can Not Fail.
(2025) Frontiers in the physiology of male pattern androgenetic alopecia: Beyond the androgen horizon.
(2025) Recent advances in alcohol metabolism: from the gut to the brain.
(2025) Type I Interferons in health and disease-Molecular aspects and clinical implications.
(2025) Sensing molecular carbon dioxide - a translational focus for respiratory disease.
(2025) Angiocrine and Pericrine Signaling: How Endothelial Cells and Pericytes Drive Cancer Progression and Therapy Resistance.
(2025) Proglucagon-derived Peptides: Human Physiology and Therapeutic Potential.
(2025) Metabolic adaptations in cancer progression.
(2025) Sex, hormones, and lung health.
(2025) Sleep's contribution to memory formation.
(2025) The anterior chamber of the eye technology and its anatomical, optical, and immunological bases.
vol.104 iss.3 (2024) Proteomics of the heart.
vol.104 iss.3 (2024) Evolution, biomechanics, and neurobiology converge to explain selective finger motor control.
vol.104 iss.3 (2024) Hepatic glucagon action: beyond glucose mobilization.
vol.104 iss.3 (2024) Ceramides are fuel gauges on the drive to cardiometabolic disease.
vol.104 iss.3 (2024) The hormonal control of parturition.
vol.104 iss.3 (2024) Navigating the multifaceted intricacies of the Na + -Cl - cotransporter, a highly regulated key effector in the control of hydromineral homeostasis.
vol.104 iss.3 (2024) Neurobiology and systems biology of stress resilience.
vol.104 iss.3 (2024) Lung endothelium, tau, and amyloids in health and disease.
vol.104 iss.2 (2024) Timing and cause of olfactory deciliation in COVID-19.
vol.104 iss.2 (2024) Cannabinoid treatments in epilepsy and seizure disorders.
vol.104 iss.2 (2024)
vol.105 iss.2 (2025) Degenerate neuronal and circuit mechanisms important for generating rhythmic motor patterns.
vol.105 iss.1 (2025) Psycho-physiological foundations of human physical activity behavior and motivation: Theories, systems, mechanisms, evolution, and genetics.
(2025) The (dys)regulation of energy storage in obesity.
(2025) Kisspeptin and Neurokinin B: roles in reproductive health.
(2025) NADPH Oxidases: Redox Regulation of Cell Homeostasis & Disease.
(2025) The TRP Channels Serving as Chemical-to-Electrical Signal Converter.
(2025) Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans.
(2025) Molecular Dissection of the Role of ACE2 in Glucose Homeostasis.
(2025) Physiologic mechanisms underlying polycystic kidney disease.
(2025) The influence of extracellular vesicles on tumor evolution and resistance to therapy.
(2025) The flux of energy in critical illness and the obesity paradox.
(2025) The pathogenesis of cerebral small vessel diseases and vascular cognitive impairment.
(2025) Neuropathological links between T2DM and LOAD: systematic review and meta-analysis.
(2025) Biomarkers of aging: from molecules and surrogates to physiology and function.
(2025) Extracellular vesicles and lung disease: from pathogenesis to biomarkers and treatments.
(2025) Transforming the concept of connectivity: unveiling tunneling nanotube biology, and their roles in brain development and neurodegeneration.
(2025) TPCs: From plant to human.
(2025) Uterine Fibroids.
(2025) A Comprehensive View of Muscle Glucose Uptake: Regulation by Insulin, Contractile Activity and Exercise.
(2025) Central nervous system mechanisms of salt-sensitive hypertension.
(2025) Deconstructing the GWAS library - Next Generation GWAS.
(2025) Immunotherapy for atherosclerosis.
(2025) Cysteine-based redox sensors in the cardiovascular system - from identification to physiology and drug discovery.
(2025) The human placenta and its role in reproductive outcomes revisited.
(2025) The physiopathology of brain-derived neurotrophic factor.
(2025) Glycerolipid Cycling in Thermogenesis, Energy Homeostasis and Signaling.
(2025) Immunomodulatory properties of transmembrane mucins: from chronic diseases to cancer.
(2025) Programmed cell death and tissue regeneration: A link that should be resolved.
(2025) Diaphragm Muscle: A Pump That Can Not Fail.
(2025) Frontiers in the physiology of male pattern androgenetic alopecia: Beyond the androgen horizon.
(2025) Recent advances in alcohol metabolism: from the gut to the brain.
(2025) Type I Interferons in health and disease-Molecular aspects and clinical implications.
(2025) Sensing molecular carbon dioxide - a translational focus for respiratory disease.
(2025) Angiocrine and Pericrine Signaling: How Endothelial Cells and Pericytes Drive Cancer Progression and Therapy Resistance.
(2025) Proglucagon-derived Peptides: Human Physiology and Therapeutic Potential.
(2025) Metabolic adaptations in cancer progression.
(2025) Sex, hormones, and lung health.
(2025) Sleep's contribution to memory formation.
(2025) The anterior chamber of the eye technology and its anatomical, optical, and immunological bases.
vol.104 iss.3 (2024) Proteomics of the heart.
vol.104 iss.3 (2024) Evolution, biomechanics, and neurobiology converge to explain selective finger motor control.
vol.104 iss.3 (2024) Hepatic glucagon action: beyond glucose mobilization.
vol.104 iss.3 (2024) Ceramides are fuel gauges on the drive to cardiometabolic disease.
vol.104 iss.3 (2024) The hormonal control of parturition.
vol.104 iss.3 (2024) Navigating the multifaceted intricacies of the Na + -Cl - cotransporter, a highly regulated key effector in the control of hydromineral homeostasis.
vol.104 iss.3 (2024) Neurobiology and systems biology of stress resilience.
vol.104 iss.3 (2024) Lung endothelium, tau, and amyloids in health and disease.
vol.104 iss.2 (2024) Timing and cause of olfactory deciliation in COVID-19.
vol.104 iss.2 (2024) Cannabinoid treatments in epilepsy and seizure disorders.
vol.104 iss.2 (2024)
